A first read on which of your products fit Brazil.
Request a 30-minute call or write to contact@southboundbr.comHow the route works
Your product, by name, in a prescription from a Brazilian physician.
Individual and personal. Products listed in Anvisa's technical note are approved automatically.
From your U.S. warehouse, through an international courier.
Ground rules. Only individuals import. No company in Brazil may import, store or resell the product. Flower and smokables are not permitted. Advertising is tightly restricted. Southbound builds the plan inside these limits.
What Southbound does
3 to 4 weeks, fixed scope
Which of your products can enter Brazil, through which channel, and what it takes. You receive a written report in English and a call to go through it.
4 to 6 months
A project led by Southbound until the first sale. You sign every contract; Southbound leads the work.
Monthly retainer
Rules change and campaigns need review. Southbound stays on as your regulatory arm in Brazil.
Ready to see what it takes to enter Brazil?
Request a 30-minute call or write to contact@southboundbr.comWho is behind it
Southbound is led by Tami Lima, a lawyer who has hands-on experience in every step Southbound now guides: regulatory approvals, contracts, advertising compliance and corporate structure.
Southbound exists so that a U.S. brand does not have to learn all of this by trial and error.
What you get
Questions brands ask
Not under the patient import route. Products on Anvisa's list of approved products are authorized automatically. Products that are not on it go through an online review, typically with no forms or extra interaction with the agency. Once a product is authorized, it joins the list, and later requests for it are approved automatically. Registering a product as a medicine in Brazil is a separate, slower path.
Not to sell through patient import. Which parts of the operation need a local presence depends on how much of the patient relationship you want to control. The diagnostic answers this for your brand.
Brands bring oils and tinctures, capsules, edibles, topicals and cosmetics through the patient route. Products legally produced in the U.S. are accepted by Anvisa. Flower, other parts of the plant and smokables are not permitted. The diagnostic answers this for your portfolio.
Only within limits. Brazilian rules treat cannabis products as medicines. Educational content, doctor engagement and social media each have their own constraints, and platforms such as Meta apply rules of their own. Our marketing playbook maps what your brand can do in each channel.
Regulation of this market keeps evolving. The monthly retainer includes regulatory monitoring, so you hear about changes early. If a change affects your operation, we can help you adapt your plan to the new rules.
No. Southbound is responsible for the analysis, the structure, the contracts and the material it delivers. Sales depend on doctors, patients and platforms.
Next step
No cost, no commitment. You leave with a first read on your portfolio. Write to:
Request a 30-minute call